A Promising Way To Treat Specific Lymphoma.
Researchers have identified a gene transmutation that may offering a target for new treatments for a type of lymphoma. The set found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalities in patients with this cancer, known as weighty B cell lymphoma. The MYD88 gene encodes a protein that is crucial for routine immune response to invading microorganisms.
The mutation identified in this study can cause uncontrolled cellular signaling, resulting in the survival of virulent cells. A subgroup of the large B cell lymphoma that has a dismally crude cure rate - known as the activated B cell-like (ABC) subtype - appears especially susceptible to the gene.
Sunday, 5 January 2020
Saturday, 4 January 2020
Cryoneedles A Possible Alternative To Botox In Fighting Against Wrinkles
Cryoneedles A Possible Alternative To Botox In Fighting Against Wrinkles.
A fresh technology that for the meantime zaps away forehead wrinkles by freezing the nerves shows assurance in early clinical trials, researchers say. The technique, if at last approved by the US Food and Drug Administration, could provide an alternative to Botox and Dysport. Both are injectable forms of Botulinum toxin typeface A, a neurotoxin that, when injected in lesser quantities, temporarily paralyzes facial muscles, thereby reducing wrinkles. "It's a toxin-free other to treating unwanted lines and wrinkles, similar to what is being done with Botox and Dysport," said deliberate over co-author Francis Palmer, director of facial plastic surgery at the University of Southern California School of Medicine in Los Angeles.
And "From the antique clinical trials, this procedure - which its maker calls cryoneuromodulation - appears to have the same clinical efficacy and cover comparable to the existing techniques". Palmer is also consulting medical supervisor of MyoScience Inc, the Redwood City (California) - based circle developing the cryotechnology. The results of the clinical trials were to be presented Friday at an American Society for Laser Medicine and Surgery (ASLMS) congress in Grapevine, Texas.
To do the procedure, physicians use slight needles - "cryoprobes" - to deliver cold to nerves continual through the forehead, specifically the temporal branch of the frontal nerve. The cold freezes the nerve, which interrupts the gall signal and relaxes the muscle that causes vertical and horizontal forehead lines. Although the temerity quickly returns to normal body temperature, the cold temporarily "injures" the nerve, allowing the beckon to remain interrupted for some period of time after the patient leaves the office.
The manner does not permanently damage the nerve. Researchers said they are still refining the technique and could not say how crave the effect lasts, but it seems to be comparable to Botox, which works for about three to four months. Physicians would call for training to identify the nerve that should be targeted.
A fresh technology that for the meantime zaps away forehead wrinkles by freezing the nerves shows assurance in early clinical trials, researchers say. The technique, if at last approved by the US Food and Drug Administration, could provide an alternative to Botox and Dysport. Both are injectable forms of Botulinum toxin typeface A, a neurotoxin that, when injected in lesser quantities, temporarily paralyzes facial muscles, thereby reducing wrinkles. "It's a toxin-free other to treating unwanted lines and wrinkles, similar to what is being done with Botox and Dysport," said deliberate over co-author Francis Palmer, director of facial plastic surgery at the University of Southern California School of Medicine in Los Angeles.
And "From the antique clinical trials, this procedure - which its maker calls cryoneuromodulation - appears to have the same clinical efficacy and cover comparable to the existing techniques". Palmer is also consulting medical supervisor of MyoScience Inc, the Redwood City (California) - based circle developing the cryotechnology. The results of the clinical trials were to be presented Friday at an American Society for Laser Medicine and Surgery (ASLMS) congress in Grapevine, Texas.
To do the procedure, physicians use slight needles - "cryoprobes" - to deliver cold to nerves continual through the forehead, specifically the temporal branch of the frontal nerve. The cold freezes the nerve, which interrupts the gall signal and relaxes the muscle that causes vertical and horizontal forehead lines. Although the temerity quickly returns to normal body temperature, the cold temporarily "injures" the nerve, allowing the beckon to remain interrupted for some period of time after the patient leaves the office.
The manner does not permanently damage the nerve. Researchers said they are still refining the technique and could not say how crave the effect lasts, but it seems to be comparable to Botox, which works for about three to four months. Physicians would call for training to identify the nerve that should be targeted.
How To Transfer One Or More Embryos Using IVF
How To Transfer One Or More Embryos Using IVF.
Women who stand in-vitro fertilization (IVF) are almost five times more conceivable to give birth to a sole healthy baby following the implantation of a single embryo than are women who choose to have two embryos implanted at the same time, an intercontinental team of experts has found. The finding comes from an analysis of facts involving nearly 1400 women who participated in one of eight different embryo transfer studies. Approximately half of the women underwent procedures involving the individual transfer of an embryo, while the other half underwent a treacherous embryo procedure.
Overall, the study authors noted that, relative to a double embryo transfer, a celibate embryo transfer appears to significantly increase the chances of carrying a baby to a uncensored term of more than 37 weeks. In addition to lowering the risk for premature birth, a only embryo transfer also appeared to lower the risk for delivering a low birth weight baby, DJ McLernon, a inspection fellow with the medical statistics team in the section of population form at the University of Aberdeen in the United Kingdom, and colleagues reported in the Dec 22 2010 online print run of BMJ.
"Our review should be useful in informing decision making regarding the number of embryos to convey in IVF," the authors wrote in their report. They added that their observations could offer sensible guidance to would-be mothers and doctors who are eager to foster optimal conditions for a successful pregnancy, while at the same lifetime hoping to avoid the increased health risks associated with IVF procedures that give take wing to multiple-birth pregnancies.
The authors concluded that doctors should advise patients to choose the single embryo carry option over what appears to be the less optimal double embryo transfer option.
At face value, the figures seemed to suggest that the double embryo transfer option does, in fact, offer the source much better odds for giving birth to a single healthy baby. While among study participants just 27 percent of lone embryo transfer procedures resulted in the birth of a healthy baby, that symbol rose to 42 percent of double embryo transfer births, the investigators found.
However, that put was narrowed considerably when the authors focused on those women undergoing an initial single embryo hand procedure who then underwent a second single implant (of a frozen embryo). That framework (in which, in essence, two single embryo transfers are conducted in sequence) prompted a 38 percent name rate - a figure just 4 percent shy of the 42 percent attainment rate attributed to two embryos being implanted simultaneously.
Women who stand in-vitro fertilization (IVF) are almost five times more conceivable to give birth to a sole healthy baby following the implantation of a single embryo than are women who choose to have two embryos implanted at the same time, an intercontinental team of experts has found. The finding comes from an analysis of facts involving nearly 1400 women who participated in one of eight different embryo transfer studies. Approximately half of the women underwent procedures involving the individual transfer of an embryo, while the other half underwent a treacherous embryo procedure.
Overall, the study authors noted that, relative to a double embryo transfer, a celibate embryo transfer appears to significantly increase the chances of carrying a baby to a uncensored term of more than 37 weeks. In addition to lowering the risk for premature birth, a only embryo transfer also appeared to lower the risk for delivering a low birth weight baby, DJ McLernon, a inspection fellow with the medical statistics team in the section of population form at the University of Aberdeen in the United Kingdom, and colleagues reported in the Dec 22 2010 online print run of BMJ.
"Our review should be useful in informing decision making regarding the number of embryos to convey in IVF," the authors wrote in their report. They added that their observations could offer sensible guidance to would-be mothers and doctors who are eager to foster optimal conditions for a successful pregnancy, while at the same lifetime hoping to avoid the increased health risks associated with IVF procedures that give take wing to multiple-birth pregnancies.
The authors concluded that doctors should advise patients to choose the single embryo carry option over what appears to be the less optimal double embryo transfer option.
At face value, the figures seemed to suggest that the double embryo transfer option does, in fact, offer the source much better odds for giving birth to a single healthy baby. While among study participants just 27 percent of lone embryo transfer procedures resulted in the birth of a healthy baby, that symbol rose to 42 percent of double embryo transfer births, the investigators found.
However, that put was narrowed considerably when the authors focused on those women undergoing an initial single embryo hand procedure who then underwent a second single implant (of a frozen embryo). That framework (in which, in essence, two single embryo transfers are conducted in sequence) prompted a 38 percent name rate - a figure just 4 percent shy of the 42 percent attainment rate attributed to two embryos being implanted simultaneously.
The Wave Of Drunkenness On American College Campuses
The Wave Of Drunkenness On American College Campuses.
With alcohol-related deaths and injuries rising on US college campuses, college officials are fatiguing various ways to quell the tide of sorrowful drinking. One effort that targeted off-campus boozing shows some promise, researchers say. A program at a bunch of public universities in California commission the level of heavy drinking at private parties and other locations by 6 percent, researchers communication in the December issue of the American Journal of Preventive Medicine. The so-called Safer California Universities lessons included measures such as stricter enforcement of local nuisance ordinances, police-run seduce operations, driving-under-the-influence checkpoints, and use of campus and local media to spread the warrant about the crackdown.
It's one of the first studies of college drinking that focuses on the environment rather than on prevention aimed at individuals, the researchers said. "The ambition was to reduce the number of big parties, which are more likely to involve threatening drinking," said lead author Robert F Saltz, senior research scientist at the Prevention Research Center, Pacific Institute for Research and Evaluation in Berkeley, Calif.
And "There's this mythos about college drinking that nothing works, and that if you do attempt to increase enforcement, students will just find some direction around it. But now we have direct evidence that these kinds of interventions can have a fairly significant impact".
Eight campuses of the University of California and six campuses in the California State University group were involved in the study. Half the schools were randomly assigned to the Safer program, which took force the fall semesters of 2005 and 2006. Student surveys were completed by undergrads in four diminish semesters (2003 through 2006), and researchers analyzed samples of 1000 to 2000 students per campus per year.
With alcohol-related deaths and injuries rising on US college campuses, college officials are fatiguing various ways to quell the tide of sorrowful drinking. One effort that targeted off-campus boozing shows some promise, researchers say. A program at a bunch of public universities in California commission the level of heavy drinking at private parties and other locations by 6 percent, researchers communication in the December issue of the American Journal of Preventive Medicine. The so-called Safer California Universities lessons included measures such as stricter enforcement of local nuisance ordinances, police-run seduce operations, driving-under-the-influence checkpoints, and use of campus and local media to spread the warrant about the crackdown.
It's one of the first studies of college drinking that focuses on the environment rather than on prevention aimed at individuals, the researchers said. "The ambition was to reduce the number of big parties, which are more likely to involve threatening drinking," said lead author Robert F Saltz, senior research scientist at the Prevention Research Center, Pacific Institute for Research and Evaluation in Berkeley, Calif.
And "There's this mythos about college drinking that nothing works, and that if you do attempt to increase enforcement, students will just find some direction around it. But now we have direct evidence that these kinds of interventions can have a fairly significant impact".
Eight campuses of the University of California and six campuses in the California State University group were involved in the study. Half the schools were randomly assigned to the Safer program, which took force the fall semesters of 2005 and 2006. Student surveys were completed by undergrads in four diminish semesters (2003 through 2006), and researchers analyzed samples of 1000 to 2000 students per campus per year.
Prolonged Use Of Statins Does Not Increase The Risk Of Cancer
Prolonged Use Of Statins Does Not Increase The Risk Of Cancer.
New explore supports the general idea that patients who take cholesterol-lowering drugs known as statins may not have an increased hazard for cancer, as some previous studies suggested. Statins are the most commonly prescribed drugs for kith and kin with high blood cholesterol levels, which are linked to heart disease. Brand names number Crestor, Lipitor and Zocor. "Three or four years ago there was a broadening of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr Valentin Fuster, by president of the American Heart Association and president of Mount Sinai Heart in New York City.
This latest study, slated for show Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc, a ensemble that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a allotment of General Electric, which provided the database for the study. Another just out study, reported Nov 10, 2010 at a assembly of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even dwindle users' risks for lymphoma, melanoma and endometrial tumors.
New explore supports the general idea that patients who take cholesterol-lowering drugs known as statins may not have an increased hazard for cancer, as some previous studies suggested. Statins are the most commonly prescribed drugs for kith and kin with high blood cholesterol levels, which are linked to heart disease. Brand names number Crestor, Lipitor and Zocor. "Three or four years ago there was a broadening of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr Valentin Fuster, by president of the American Heart Association and president of Mount Sinai Heart in New York City.
This latest study, slated for show Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc, a ensemble that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a allotment of General Electric, which provided the database for the study. Another just out study, reported Nov 10, 2010 at a assembly of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even dwindle users' risks for lymphoma, melanoma and endometrial tumors.
Choice Of Place Of Death From Cancer
Choice Of Place Of Death From Cancer.
Doctors who would opt hospice anguish for themselves if they were dying from cancer are more likely to discuss such care with patients in that situation, a different study finds in Dec 2013. And while the majority of doctors in the study said they would essay hospice care if they were dying from cancer, less than one-third of those said they would discuss hospice care with terminally vile cancer patients at an early stage of care. Researchers surveyed nearly 4400 doctors who charge for cancer patients, including primary care physicians, surgeons, oncologists, dispersal oncologists and other specialists. They were asked if they would want hospice care if they were terminally ill with cancer.
They were also asked when they would examine hospice care with a patient with terminal cancer who had four to six months to persevere but had no symptoms: immediately; when symptoms first appear; when there are no more cancer treatment options; when the patient is admitted to hospital; or when the valetudinarian or family asks about hospice care. In terms of seeking hospice punctiliousness themselves, 65 percent of doctors were strongly in favor and 21 percent were less in favor.
Doctors who would opt hospice anguish for themselves if they were dying from cancer are more likely to discuss such care with patients in that situation, a different study finds in Dec 2013. And while the majority of doctors in the study said they would essay hospice care if they were dying from cancer, less than one-third of those said they would discuss hospice care with terminally vile cancer patients at an early stage of care. Researchers surveyed nearly 4400 doctors who charge for cancer patients, including primary care physicians, surgeons, oncologists, dispersal oncologists and other specialists. They were asked if they would want hospice care if they were terminally ill with cancer.
They were also asked when they would examine hospice care with a patient with terminal cancer who had four to six months to persevere but had no symptoms: immediately; when symptoms first appear; when there are no more cancer treatment options; when the patient is admitted to hospital; or when the valetudinarian or family asks about hospice care. In terms of seeking hospice punctiliousness themselves, 65 percent of doctors were strongly in favor and 21 percent were less in favor.
Friday, 3 January 2020
Scientists Can Not Determine The Cause Of Autism
Scientists Can Not Determine The Cause Of Autism.
Some children who are diagnosed with autism at an first mature will ultimately shed all signs and symptoms of the ailment as they enter adolescence or young adulthood, a new analysis contends. Whether that happens because of aggressive interventions or whether it boils down to biology and genetics is still unclear, the researchers noted, although experts suspected it is most likely a organization of the two. The finding stems from a methodical analysis of 34 children who were deemed "normal" at the study's start, ignoring having been diagnosed with autism before the age of 5.
So "Generally, autism is looked at as a lifelong disorder," said ponder author Deborah Fein, a professor in the departments of feeling and pediatrics at the University of Connecticut. "The point of this work was really to demonstrate and detail this phenomenon, in which some children can move off the autism spectrum and really go on to function like normal adolescents in all areas, and end up mainstreamed in harmonious classrooms with no one-on-one support.
And "Although we don't know particularly what percent of these kids are capable of this kind of amazing outcome, we do know it's a minority. We're certainly talking about less than 25 percent of those diagnosed with autism at an primitive age. "Certainly all autistic children can get better and broaden with good therapy. But this is not just about good therapy. I've seen thousands of kids who have great analysis but don't reach this result. It's very, very important that parents who don't meditate this outcome not feel as if they did something wrong".
Fein and her colleagues reported the findings of their study, which was supported by the US National Institutes of Health, in the Jan. 15 issuing of the Journal of Child Psychology and Psychiatry. The 34 individuals then diagnosed with autism (most between the ages of 2 and 4) were ineptly between the ages of 8 and 21 during the study. They were compared to a group of 44 individuals with high-functioning autism and a manage group of 34 "normal" peers.
In-depth blind analysis of each child's real diagnostic report revealed that the now-"optimal outcome" group had, as young children, shown signs of public impairment that was milder than the 44 children who had "high-functioning" autism. As childlike children, the now-optimal group had suffered from equally severe communication impairment and repetitive behaviors as those in the high-functioning group.
Some children who are diagnosed with autism at an first mature will ultimately shed all signs and symptoms of the ailment as they enter adolescence or young adulthood, a new analysis contends. Whether that happens because of aggressive interventions or whether it boils down to biology and genetics is still unclear, the researchers noted, although experts suspected it is most likely a organization of the two. The finding stems from a methodical analysis of 34 children who were deemed "normal" at the study's start, ignoring having been diagnosed with autism before the age of 5.
So "Generally, autism is looked at as a lifelong disorder," said ponder author Deborah Fein, a professor in the departments of feeling and pediatrics at the University of Connecticut. "The point of this work was really to demonstrate and detail this phenomenon, in which some children can move off the autism spectrum and really go on to function like normal adolescents in all areas, and end up mainstreamed in harmonious classrooms with no one-on-one support.
And "Although we don't know particularly what percent of these kids are capable of this kind of amazing outcome, we do know it's a minority. We're certainly talking about less than 25 percent of those diagnosed with autism at an primitive age. "Certainly all autistic children can get better and broaden with good therapy. But this is not just about good therapy. I've seen thousands of kids who have great analysis but don't reach this result. It's very, very important that parents who don't meditate this outcome not feel as if they did something wrong".
Fein and her colleagues reported the findings of their study, which was supported by the US National Institutes of Health, in the Jan. 15 issuing of the Journal of Child Psychology and Psychiatry. The 34 individuals then diagnosed with autism (most between the ages of 2 and 4) were ineptly between the ages of 8 and 21 during the study. They were compared to a group of 44 individuals with high-functioning autism and a manage group of 34 "normal" peers.
In-depth blind analysis of each child's real diagnostic report revealed that the now-"optimal outcome" group had, as young children, shown signs of public impairment that was milder than the 44 children who had "high-functioning" autism. As childlike children, the now-optimal group had suffered from equally severe communication impairment and repetitive behaviors as those in the high-functioning group.
Thursday, 2 January 2020
Still Some Differences Between The Behavior Of Men And Women
Still Some Differences Between The Behavior Of Men And Women.
While not every broad is intuitive or every guy handy with tools, neurological scans of progeny males and females suggest that - on average - their brains really do develop differently. The digging comes with a caveat: It doesn't connect the brain-scan findings to the actual ways that these participants conduct in real life. And it only looks at overall differences among males and females. Still, the findings "confirm our hunch that men are predisposed for rapid action, and women are predisposed to cogitate about how things feel," said Paul Zak, who's familiar with the study findings.
And "This remarkably helps us understand why men and women are different," added Zak, founding chief honcho of the Center for Neuroeconomics Studies at Claremont Graduate University in California. Researchers Ragini Verma, an affiliate professor of radiology at the University of Pennsylvania, and colleagues used scans to study the brains of 428 males and 521 females aged 8 to 22.
The goal was to better realize the connectivity in the brain and determine if certain types of wiring are in good shape or like a lane "that could be broken or has a bad rough patch that needs to be covered over". The swat found that, on average, the brains of men seem to be better equipped to comprehend what people perceive and how they react to it. Females, on average, appear to be better able to stick the parts of their brains that handle analysis and intuition.
While not every broad is intuitive or every guy handy with tools, neurological scans of progeny males and females suggest that - on average - their brains really do develop differently. The digging comes with a caveat: It doesn't connect the brain-scan findings to the actual ways that these participants conduct in real life. And it only looks at overall differences among males and females. Still, the findings "confirm our hunch that men are predisposed for rapid action, and women are predisposed to cogitate about how things feel," said Paul Zak, who's familiar with the study findings.
And "This remarkably helps us understand why men and women are different," added Zak, founding chief honcho of the Center for Neuroeconomics Studies at Claremont Graduate University in California. Researchers Ragini Verma, an affiliate professor of radiology at the University of Pennsylvania, and colleagues used scans to study the brains of 428 males and 521 females aged 8 to 22.
The goal was to better realize the connectivity in the brain and determine if certain types of wiring are in good shape or like a lane "that could be broken or has a bad rough patch that needs to be covered over". The swat found that, on average, the brains of men seem to be better equipped to comprehend what people perceive and how they react to it. Females, on average, appear to be better able to stick the parts of their brains that handle analysis and intuition.
Scientists Concerned About The Amount Of Fat And Trans Fats In Food
Scientists Concerned About The Amount Of Fat And Trans Fats In Food.
Fears that removing c baneful trans fats from foods would unfilled the door for manufacturers and restaurants to annex other harmful fats to foods seem to be unfounded, a new consider finds. A team from Harvard School of Public Health analyzed 83 reformulated products from supermarkets and restaurants, and found petty cause for alarm. "We found that in over 80 brand name, biggest national products, the great majority took out the trans fat and did not just replace it with saturated fat, suggesting they are using healthier fats to put back the trans fat," said lead researcher Dr Dariush Mozaffarian, an underling professor of epidemiology.
Trans fats - created by adding hydrogen to vegetable lubricant to make it firmer - are cheap to produce and long-lasting, making them ideal for fried foods. They also combine flavor that consumers like, but are known to decrease HDL, or good, cholesterol, and advance LDL, or bad, cholesterol, which raises the risk for heart attack, iota and diabetes, according to the American Heart Association. The report, published in the May 27 son of the New England Journal of Medicine, found no increase in the use of saturated fats in reformulated foods sold in supermarkets and restaurants.
Baked goods were the only exception. Mozaffarian said trans yield was replaced by saturated plump in some bakery items, but they were the minority of products studied. Saturated fats have been associated in experimentation studies with an increased risk of atherosclerosis, diabetes and arterial inflammation.
The big up-front cost to industriousness is reformulating the product. "When industry and restaurants go through that effort, they are recognizing that, 'We might as well elect the food healthier,' and in the great majority of cases they are able to do so. So, I think that there is greater concentration to health than ever before, and industry and restaurants are trying to do the right thing".
Fears that removing c baneful trans fats from foods would unfilled the door for manufacturers and restaurants to annex other harmful fats to foods seem to be unfounded, a new consider finds. A team from Harvard School of Public Health analyzed 83 reformulated products from supermarkets and restaurants, and found petty cause for alarm. "We found that in over 80 brand name, biggest national products, the great majority took out the trans fat and did not just replace it with saturated fat, suggesting they are using healthier fats to put back the trans fat," said lead researcher Dr Dariush Mozaffarian, an underling professor of epidemiology.
Trans fats - created by adding hydrogen to vegetable lubricant to make it firmer - are cheap to produce and long-lasting, making them ideal for fried foods. They also combine flavor that consumers like, but are known to decrease HDL, or good, cholesterol, and advance LDL, or bad, cholesterol, which raises the risk for heart attack, iota and diabetes, according to the American Heart Association. The report, published in the May 27 son of the New England Journal of Medicine, found no increase in the use of saturated fats in reformulated foods sold in supermarkets and restaurants.
Baked goods were the only exception. Mozaffarian said trans yield was replaced by saturated plump in some bakery items, but they were the minority of products studied. Saturated fats have been associated in experimentation studies with an increased risk of atherosclerosis, diabetes and arterial inflammation.
The big up-front cost to industriousness is reformulating the product. "When industry and restaurants go through that effort, they are recognizing that, 'We might as well elect the food healthier,' and in the great majority of cases they are able to do so. So, I think that there is greater concentration to health than ever before, and industry and restaurants are trying to do the right thing".
Preparation For Colonoscopy As A Tablet Relieves Suffering From The Procedure
Preparation For Colonoscopy As A Tablet Relieves Suffering From The Procedure.
One saneness many colonize dread a colonoscopy is the unpleasant preparation, which often requires that they liquid refreshment a gallon of prescribed fluids to clear out their bowels before the procedure. But an industry-funded haunt suggests that a pill could negate the need for so much liquid. Researchers from Henry Ford Hospital story that people preparing for the test were able to take a pill approved as a treatment for chronic constipation and keep off half of the liquid requirement.
In the study, 126 people took either the pill - lubiprostone (Amitiza) - or an sluggish placebo. Those who took the combination of the pill and liquid were better able to suffer the preparation than were those who drank a gallon of a mixture of polyethylene glycol and electrolytes, the study found. "Most bourgeoisie say they don't want to have a colonoscopy because they find the preparation intolerable," the study's lead author, Dr Chetan Pai, a gastroenterologist, said in a telecast release from the hospital.
So "If physicians are able to present oneself a better way to prep, I think this will encourage more people to get the colonoscopies that may save their lives". Pai also spiked out that about 90 percent of colon cancer cases occur in people older than 50, an majority group that tends to have an especially hard time drinking the gallon of liquid often prescribed for colonoscopy preparation. The study, scheduled to be presented Sunday at the Digestive Diseases Week seminar in New Orleans, was funded by the pill's industrialist Sucampo Pharmaceuticals.
A colonoscopy is an internal exam of the colon (large intestine) and rectum, using an instrument called a colonoscope. How the Test is Performed. The colonoscope has a minute camera attached to a flexible tube. Unlike sigmoidoscopy, which can only stir the lower third of the colon, colonoscopy examines the entire length of the colon.
One saneness many colonize dread a colonoscopy is the unpleasant preparation, which often requires that they liquid refreshment a gallon of prescribed fluids to clear out their bowels before the procedure. But an industry-funded haunt suggests that a pill could negate the need for so much liquid. Researchers from Henry Ford Hospital story that people preparing for the test were able to take a pill approved as a treatment for chronic constipation and keep off half of the liquid requirement.
In the study, 126 people took either the pill - lubiprostone (Amitiza) - or an sluggish placebo. Those who took the combination of the pill and liquid were better able to suffer the preparation than were those who drank a gallon of a mixture of polyethylene glycol and electrolytes, the study found. "Most bourgeoisie say they don't want to have a colonoscopy because they find the preparation intolerable," the study's lead author, Dr Chetan Pai, a gastroenterologist, said in a telecast release from the hospital.
So "If physicians are able to present oneself a better way to prep, I think this will encourage more people to get the colonoscopies that may save their lives". Pai also spiked out that about 90 percent of colon cancer cases occur in people older than 50, an majority group that tends to have an especially hard time drinking the gallon of liquid often prescribed for colonoscopy preparation. The study, scheduled to be presented Sunday at the Digestive Diseases Week seminar in New Orleans, was funded by the pill's industrialist Sucampo Pharmaceuticals.
A colonoscopy is an internal exam of the colon (large intestine) and rectum, using an instrument called a colonoscope. How the Test is Performed. The colonoscope has a minute camera attached to a flexible tube. Unlike sigmoidoscopy, which can only stir the lower third of the colon, colonoscopy examines the entire length of the colon.
Subscribe to:
Posts (Atom)